Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: BIOLEGEND, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-03-31 to 2025-05-21
Current total value of award: $14906.75
Description: ANTIBODIES FOR CLINICAL TRIAL PROTOCOL, WE WILL BE PERFORMING MULTI-PARAMETER FLOW-CYTOMETRIC ANALYSES FOR CIRCULATING IMMUNE SUBSETS ON OVER 230 CLINICAL SAMPLES, REQUIRING 30 DIFFERENT ANTIBODIES.  THIS IS TO PROVIDE THE MAJORITY OF PHARMACODYNAMIC